Term
|
Definition
have receptors in almost every cell |
|
|
Term
|
Definition
inc glucose production at the expense of protein and muscle. |
|
|
Term
|
Definition
stimulates gluconeogenesis |
|
|
Term
|
Definition
cause hypergylcemia, and DM |
|
|
Term
|
Definition
stimulate storage of glucose in liver as glycogen. |
|
|
Term
|
Definition
induce lipolysis in extremities, and lipogenesis in trunkand face |
|
|
Term
|
Definition
Catabolic effects: thinning of skin, reduced mm mass |
|
|
Term
|
Definition
blcok action of calcitriol. used to treat hypercalcemia. |
|
|
Term
|
Definition
Anti-inflammation: reduce pain, heat redness, and swelling |
|
|
Term
|
Definition
indirectly phospholipase a2 by inc lipocortin. which blocks prod. of arachidonic acid. thus dec prostaglandins and leukotrienes |
|
|
Term
|
Definition
cause some vasoconstriction and inhibit release of histamine. |
|
|
Term
|
Definition
dec cell-mediated immunity. USed for a varitey of AI diseases |
|
|
Term
|
Definition
|
|
Term
|
Definition
long term use leads to osteoporosis, where as short term use treat hypercalcemia |
|
|
Term
|
Definition
|
|
Term
|
Definition
hepatic and renal metabolism |
|
|
Term
|
Definition
|
|
Term
|
Definition
only free drug can cross placenta, be metabolized and cross membrane. |
|
|
Term
|
Definition
|
|
Term
synthetic glucocorticoids |
|
Definition
used to treat inflammatory, AI, or allergic response |
|
|
Term
|
Definition
|
|
Term
|
Definition
4X as potent as cortisone |
|
|
Term
|
Definition
intermediate acting syn. glucocorticoid.
mainly used topically. |
|
|
Term
|
Definition
10X as potent as cortisol |
|
|
Term
Dexamethasone and betamethasone |
|
Definition
MOST POTENT syn. glucocorticoid. 25X as potent as cortisol |
|
|
Term
Dexamethasone and betamethasone |
|
Definition
better topically than triamcinolone, due to it being more hydrophilic |
|
|
Term
Triamcinolone, dexamethasone, betamethasone |
|
Definition
DONT have mineralocorticoid activity. |
|
|
Term
declomethasone, budesonide, ciclesone, flunisolide, fluticasone, ,mometasone |
|
Definition
Locally acting glucocorticoids. used mainly to prevent asthma or allergic rhinitis |
|
|
Term
declomethasone, budesonide, ciclesone, flunisolide, fluticasone, ,mometasone |
|
Definition
rapidly absorbed with few systemic SEs |
|
|
Term
declomethasone, budesonide, ciclesone, flunisolide, fluticasone, ,mometasone |
|
Definition
contain an ester at 17 position which is removed by esterase as soon as it enters blood. |
|
|
Term
fluticasone/hydrocortisone |
|
Definition
used as treatment for Addison's dse |
|
|
Term
|
Definition
treats secondary adrenoinsuff. may need minerocorticoid as well, but depends on pt |
|
|
Term
|
Definition
due to enzyme def. of 21B-hydroxylase. this causes dec cortisol and aldosterone |
|
|
Term
|
Definition
|
|
Term
|
Definition
used to distinguish bw cushing dse and syndrome |
|
|
Term
|
Definition
used in premature deliveries. has less protein binding so more can cross placentea and inc surfactant production. |
|
|
Term
|
Definition
aldosterone antagonist, inhibtis na resaborb. treats hypokalemia.
also blocks androgen receptor, leading to gynecomastia |
|
|
Term
|
Definition
aldosterone antagonist, treats HTN and CHF |
|
|
Term
|
Definition
glucocorticoid receptor antagonist, rapid dislocation of the drug leads to faulty translocation. |
|
|
Term
|
Definition
used for aboriton in first 3 mo. and as morning after pill |
|
|
Term
Mifepristone, ketoconazole, and metyrapone |
|
Definition
experimentally used to treat cushings dse |
|
|
Term
|
Definition
antifungal that blocks synthesis of adrenal and gonadal steroids. blocks synthesis of all 5 steroids |
|
|
Term
|
Definition
only blocks cortisol synthesis |
|
|
Term
|
Definition
blocks 11B-hydroxylase.
inc secretion of 11-hydroxycortisone and androgens. |
|
|
Term
|
Definition
AE: hirsutism and na retention |
|
|
Term
synthetic glucocorticoids |
|
Definition
inc half-life and DOA compared to cortisol. |
|
|
Term
synthetic glucocorticoids |
|
Definition
dec salt-retaining activity adn enhanced penetration of lipid barriers for topical use compared to cortisol |
|
|